CVS faces lawsuit over illegal opioid prescriptions

DOJ sues CVS for illegal opioid prescriptions, contributing to the opioid crisis, alleging violations of controlled substance laws and performance-driven actions leading to patient overdoses.

US accuses CVS of filling, billing government for illegal opioid prescriptions

The DOJ lawsuit against CVS accuses the chain of filling illegal opioid prescriptions, ignoring red flags, and contributing to the opioid epidemic, leading to patient fatalities.

Steps to rein in pharmacy benefit managers in US bill "manageable" for firms

The article discusses a new stopgap bill regarding healthcare provisions, focusing on its implications for pharmacy benefit managers and drug pricing in the U.S.

UnitedHealth, Cigna, other managed-care stocks rise as selloff seen as overdone

Managed care stocks rebounded as investors reassess healthcare provisions affecting PBMs, finding them less stringent than anticipated, leading to stock price increases for UnitedHealth, CVS, and Cigna.

US health-care stocks dip on Trump's commitment to PBM reform

Shares of healthcare companies with pharmacy benefit management units fell again, following Pfizer CEO's comments on Trump's intent to reform the PBM system, viewed as a source of rising drug costs.

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.25%

U.S. stocks were mixed, with significant gains in Consumer Goods and Technology sectors, while Telecoms and Oil & Gas sectors declined. Notable performances by Broadcom and Tesla.

Insurer stocks fall after Trump says 'we're going to knock out the middleman'

Trump's criticism of pharmacy benefit managers caused shares of major health insurers to drop, igniting debate about drug pricing and proposals to eliminate middlemen in the industry.

Pharmacy benefit manager stocks dip following Trump's vow to cut drug costs

Trump's plan to cut out PBMs led to significant stock declines for major companies, highlighting bipartisan legislative efforts to reform the pharmaceutical industry.

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.22%

Healthcare stocks dip on potential PBM legislation

Shares of US healthcare companies drop due to proposed legislation targeting pharmacy benefit managers, which aims to force them to divest their owned pharmacies.